ADIAL PHARMACEUTICALS, INC. (ADIL)
↓ Download CSVKey ratios (FY2025)
-151.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$7.80M | -$8.28M | -$6.89M | -$10.86M | -$19.29M | -$10.93M | -$8.24M | -$6.99M | -$995.3K | — |
| Net Income | -$7.98M | -$13.20M | -$5.12M | -$12.73M | -$19.42M | -$10.89M | -$8.59M | -$11.63M | -$1.14M | — |
| EPS (Diluted) | $-11.93 | $-68.01 | $-3.60 | $-12.71 | $-1.04 | — | — | — | — | — |
| Total Assets | $6.67M | $5.04M | $4.74M | $5.73M | $7.47M | $5.49M | $7.68M | $4.70M | $34.5K | — |
| Total Liabilities | $1.40M | $975.9K | $653.1K | $2.46M | $3.97M | $1.51M | — | — | — | — |
| Shareholders' Equity | $5.28M | $4.07M | $4.08M | $3.28M | $3.51M | $3.99M | $7.14M | $4.44M | -$997.6K | -$103.5K |
| Cash & Equivalents | $5.88M | $3.75M | $2.83M | $4.00M | $6.06M | $4.40M | $6.78M | $3.87M | $18.2K | $88.0K |
| Operating Cash Flow | -$6.49M | -$6.92M | -$6.81M | -$11.19M | -$11.95M | -$7.63M | -$6.34M | -$2.50M | -$494.9K | — |
| Capital Expenditures | — | — | — | — | $64.6K | — | — | — | — | — |
| Shares Outstanding | 1.11M | 258.8K | 1.66M | 1.07M | 20.95M | 14.39M | 10.37M | 6.86M | 3.27M | — |